MAUI, Hawaii, Oct. 4 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. (Pink Sheets: BPYT) ("Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced today that it has retained OTC Financial Network, a division of National Financial Communications Corporation, as its investor relations representative.
Sales of CAM reached $5 billion in 2005, and approximately 62% of U.S. adults are using some form of CAM for preventing and managing chronic disease, according to Med Ad News. Geoffrey Eiten, president of National Financial Communications, commented, "Bioponic has developed a patented, new natural healing modality and an extensive suite of branded product lines that serve explosive growth in alternative medicine."
Eiten says, "Several independent research studies suggest turmeric, a key ingredient in Bioponic's Curecurmin(TM) product can provide efficacious and natural treatment to some of the world's most prevalent, incurable diseases." Independent research studies on the anti-cancer properties of turmeric suggests that curcumin has the potential for treatment of five top cancers in the U.S. -- colon, breast, prostate, lung and skin. Additionally, UCLA/VA researchers found that curcumin -- a chemical found in curry and turmeric -- may help the immune system clear the brain of amyloid beta, which forms the plaques found in Alzheimer's disease. See the press release at http://www.j-alz.com/press/2006/20061003.html.
"This is a truly an exciting revelation in Bioponic's history, and we think investors will be interested in following this company closely. We look forward to representing Bioponic to the financial community and helping it to achieve greater market exposure," added Eiten.
Steven M. Schorr, Chairman & CEO of Bioponic, said, "We have retained
|SOURCE Bioponic Phytoceuticals, Inc.|
Copyright©2007 PR Newswire.
All rights reserved